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ABSTRACT
The authors present their initial experience in phy.sical aspects of treatment planning in HDR intraoperative
brachytherapy. The examples are given of implantations in various tumour localizations: head and neck, pancreas,
soft tissue sarcomas in the abdomen. The technical and dosimetric problems which may occur in such situations are
discussed. The capabilities of dose distribution optimization by the Abacus HDR treatment planning system are
presented.
INTRODUCTION
Intraoperative radiotherapy (IORT) is a
promising modality with which it is possible to
increase tumour dose and, therefore, tumour
control, without increasing therapy-induced
morbidity. It has the distinct advantage of
directly irradiating the tumour bed, while
eliminating the surrounding normal tissues and
organs from the field of treatment. The
combination of maximal tumour irradiation and
minimal normal tissue irradiation can maximize
the therapeutic ratio and the efficacy of the
treatment. Intraoperative radiotherapy is
especially useful when the required radiation.
dose exceeds the tolerance dose of the
surrounding normal tissues.
However, the application of IORT with
external beams has been significantly limited
by cost, logistic issues, and technical
problems. On the other hand, intraoperative
brachytherapy makes it possible to deliver
treatment to difficult anatomic areas. The high
dose rate (HDR) afterloading brachytherapy is
a very suitable method, being cost effective,
logistically sound, and suitable for a wide
range of anatomic sites (Verniers, 1992). The
inherent possibilities of remote afterloading
HDR techniques offer several important
advantages over conventional LDR
techniques. They improve radiation protection
of the medical and nursing staff, and
significantly facilitate the optimization of dose
distribution.
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The intraoperative HDR brachytherapy in
most cases is performed as a multi-fraction
irradiation when the HDR catheters are placed
and sutured to the tumour bed during the
surgery and left there with their open ends
sticking out through the surgical scar. Several
days after the surgery, when the post surgery
swelling has stabilized, the actual catheter
position may be accurately established by
radiography and irradiation may be planned.
The intraoperative brachytherapy
applications in our department are limited so
far to pancreatic tumours, soft tissue
sarcomas, and head and neck tumours. The
aim of this paper is to present our initial
experience in physical aspects of treatment
planning and dose distribution optimization in
HDR intraoperative brachytherapy.
MATERIALS AND METHODS
Since 1996 we have treated intraoperatively
over 50 patients for pancreatic tumours, soft
tissue sarcomas, and head and neck tumours.
All the irradiations were performed using the
Gammamed 12i stepping source afterloader
with the Ir-192 source provided by the
Isotopen-Technik Dr.Sauerwein GmbH. The
activity of the source was between 10 Ci (new
source) and 5 Ci (before source replacement).
The treatment times ranged between 5 - 15
minutes per fraction.
Dose distributions were calculated and
optimized using the Abacus 1.6 treatment
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planning software from the same company.
3-D dose volume histograms (DVH) were used
for comparison of various treatment plans.
A detailed analysis of the functioning of the
optimization algorithm will be the topic of
another paper.
Pancreas
Intraoperative interstitial brachytherapy has
been used during laparotomy for tumours
localized in the pancreas. The volume to be
implanted is determined by measuring three
mutually perpendicular dimensions of the
tumour during laparatomy [Bodner, 1997]. The
extent of the tumour is marked by surgical
clips. Flexible guide tubes are used. The size
and shape of the tumour determine the
number of catheters. The catheters are
inserted into the pancreatic tumour and are as
parallel to each other as possible. The optimal
distance between the catheters is approx. 1
em but in clinical situations in most cases it is
impossible to fix them parallel to each other.
The catheter localization was done by two
orthogonal X-ray films and CT examination.
The target volume was defined as a volume
including all surgical clips with a 1 cm margin.
In a group of 30 patients treated this way, the
tumour dose was 30 Gy in daily fractions of 3
Gy in a continuous regime (including week-
end). Seven days later, brachytherapy was
followed by a radio-chemotherapy treatment ,
with the external beam tumour dose of 45 Gy,
combined with two 5 day courses of 5Fu as a
radiosensitizer. In most cases, a three field
technique was used: one frontal field and two
lateral wedge fields.
Head and Neck
When cancer recurs in an area of earlier
radiation, further external beam irradiation is
usually impossible. Salvage surgery alone has
a low curative potential and, therefore, should
be combined with interstitial intraoperative
brachytherapy (Harrison, 1997). Because of
the specific anatomical situation, precise
intraoperative tumour volume definition is very
difficult. In these regions, large margins (2.5
em) around the resected area should be
irradiated. Flexible guide tubes are implanted
parallel to each other with a 1.5 cm distance
,between them. The day after the operation the
localization of the catheters is established by
two orthogonal X-ray films. Target volume
delineation is based on the pre-surgery CT
examination, check films and intraoperative
examination. In a group of 12 patients treated
up till now, a tumour dose of 40 Gy was
delivered in 3 Gy fractions two times a day
with a 6 hour interval (13 fractions in 7 days).
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Soft tissue sarcomas (STS)
In STS two different clinical situations occur.
When the tumour is localized in the
extremities, the target volume delineation is
relatively easy. The tumour bed after primary
tumour resection should be encompassed by
the isodose corresponding to the curative
dose. The number of catheters is determined
by the size of the tumour bed and in most
cases it is possible to place them fairly parallel
to each other and in equidistant positions
(Harrison, 1993). When the STS is localized in
the extraperitoneal region it requires a cyto-
reductive operation and careful placement of
surgical clips. Target delineation is based
mainly on the orthogonal X-ray films, CT scans
and intraoperative examination. The margins
should be as large as possible, a limiting factor
being the neighbouring late reacting organs at
risk [Hilaris, 1997]. Dosage and fractionation in
our group of 9 patients were individualized
according to the clinical and histological
situation and to previous radiotherapy
treatment.
DISCUSSION
Once the catheters are placed in the patient,
stepping source brachytherapy offers two
degrees of freedom: the dwell position and the
dwell time. Usually the dwell positions are
placed in the sections of the catheters, which
are inside the target volume. Then optimization
of the dose distribution is performed by
manipulation of the dwell times by dedicated
software. Because brachytherapy radiation
begins within two-three days after the
operation, it gives the physicist enough time to
work out an optimal treatment plan. The
optimized isodose distribution should match
the requirements specified by the physician
and fulfil the recommendations of the ICRU on
dose and volume specifications for reporting
interstitial therapy (ICRU, 1997).
Despite the efforts of radiotherapists to follow
the rules of proper catheter placement during
the implantation procedure, in numerous cases
the resulting distribution of catheters is far from
being ideal. According to our experience, the
HDR treatment planning may pose certain
technical problems. The eventual position of
the catheters may differ from that planned,
some of the catheters may get bent to such an
extent that the source cannot be entered into
them, etc. In Figs. 1 and 2 we show two
pancreatic tumour implants. One implant
follows relatively well the rules of the Paris
System, while the other clearly ,does not. Fig. 3
presents the dose distribution in 3D for the
latter implant, which was attained thanks to the
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optimization procedures of the Abacus treatment
planning system. The optimization is based on a
set of predefined dose points at the borders of
the target volume which are supposed to receive
a predefined dose. The dose points are
automatically generated by the planning software
at equal distances from peripheral catheters.
The mathematical optimization, called
optimization on distance, aims at determining
the dwell positions and relative dwell times
such that the reference isodose surface
passes through these dose points (Van der
Laarse, 1991). The 1.6 version of the Abacus
planning software provides the option of
entering additional user-defined dose points
inside the target volume, which improves
optimization capabilities.
Fig. 1. Pancreatic tumour implant The catheters are fairly parallel to each other. It is relatively
easy to get afomogeneous dose distribution.
FIg. 2. Pancreatic tumour implant. Six catheters within the
target volume are clearly not parallel to each other,
which largely complicates the optimization of the
dose distribution.
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Fig. 3. The dose distribution in 3-D for the implant presented
in Fig. 2. The optimization procedures of the planning
software made it possible to get quite satisfying dose
distribution for a relatively irregular implant. The 3 Gy
isodose surface is presented together with lhe
position ofcatheters (red) and reference points (blue).
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The next set of illustrations presents an
example of the brachytherapy of the STS in
the abdominal region. Five guide tubes were
implanted fairly parallel to each other.
However, it turned out that one of them was
too tightly sutured and the source could not
enter into it. The treatment plan had to be
prepared for four out of five catheters. The
optimization was still based on the dose points
as defined for the five catheter implant.
Fig. 4. Soft tissue sarcoma (STS) implant in the abdominal
region. Five catheters are implanted fairly parallel to
each other. One of the catheters, too tightly sutured,
did not let the source in. Later, during the treatment.
the second catheter became unusable and the
treatment had to be re-planned. The position of active
and inactive catheters is shown in Figs. 5 and 6.
The resultant dose distribution is presented in
Fig. 5. After several fractions the situation
became even worse because one more
catheter became unusable. The treatment had
to be re-planned and the resultant dose
distribution is presented In Fig. 6. The
reference isodose still encompasses the target
volume. The analysis of the 3-D DVH's for the
two plans shows that the volume
encompassed by the 1.5 Gy isodose
- (reference Isodose optimized to the same set
of predefined reference points) increased only
by 5% and that of 1 Gy isodose by 7.5%. The
volume of 2.25 Gy isodose (150% of the
reference dose) decreased by about 1% and
the volume of 3 Gy isodose decreased by 7%.
This proves the versatility of the Abacus
optimization procedure. The relatively small
changes in dose homogeneity are not likely to
cause any late complications.
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Fig. 5. The dose distribution for the implant presented in Fig.
4. Four out five catheters (1, 2, 3, 4) are used for
treatment. The reference isodose of 1.5 Gy covers
the target volume.
Fig. 6. The dose distribution for the implant presented in Fig.
4. Three out of five catheters (1, 3, 4) are used for
treatment. The reference isodose of 1.5 Gy still
encompasses the target volume. The difference in
homogeneity is discussed in the text.
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To summarize, it should be emphasized that
the quality of brachytherapy applications
depends on the choice of the target volume,
dose distribution homogeneity, and on
radiation injury to critical tissues. The individual
adjustment of the dose shape to the target
volume by careful treatment planning is
essential for better treatment quality. Imaging
methods play a significant role in planning
procedures. In order to define the target
volume properly various imaging techniques
may be used: orthogonal X-rays, CT, etc. The
dose distribution calculations should be
performed in 3-D for better evaluation of the
treatment plan. However, one should bear in
mind that with all the computer power, display
techniques and optimization methods
available, the degree to which a brachytherapy
implant will be effective is determined not by
how well the implant is optimized, but how well
the physician has physically placed the
catheters or applicators. The optimization
software cannot provide a good dose
distribution around a badly placed implant.
CO'NCLUSIONS
1. If the placement rules for the catheters of a
given target volume are not adhered to, it is
difficult, if not impossible, to obtain a good
dose distribution;
2. A mathematically optimized dose distribution
does not always represent the best possible
distribution in and around the implant, it
depends very much on the number and
positions of the selected dose points;
3. If an implant is not covering the target
volume geometrically, special techniques,
manual or' mathematical, of changing
relative dwell times may be required to
cover the target volume with the reference
isodose surface;
4. Clinical experience is always required to
evaluate the mathematically optimized dose
distribution for actual patient treatment.
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